Biologics News

Significant cell death and proinflammatory mediator production resulted when synovial cells were treated with leukocyte-rich platelet-rich plasma and red blood cell concentrate, according to study results.

Bioventus recently launched the next generation of its EXOGEN Ultrasound Bone Healing System.

Orthopedics Today has highlighted the seven most important stories of the year to keep your practice up-to-date regarding stem cells in orthopedic medicine.

Eight years after undergoing implantation of olfactory mucosal cells to repair a complete spinal cord injury, a patient was found to have developed an intramedullary spinal cord mass at the site of cell implantation — the first case of its kind, researchers reported.

Study results presented at the European League Against Rheumatism Annual Congress identified a correlation between micro RNAs and the development of severe osteoarthritis of the knee or hip joint, suggesting that micro RNAs may be used as predictive biomarkers.

Mitek Sports Medicine launched Monovisc High Molecular Weight Hyaluronan and the PEAK Platelet-Rich Plasma System at the American Orthopaedic Society for Sports Medicine Annual Meeting.

Platelet-rich plasma injection did not improve pain and shoulder function in patients with rotator cuff tendinopathy any more than placebo, according to study results.

During operative treatment of Vancouver B1 fractures, recent study results showed allograft struts should be used cautiously due to increased infection and time to union.

Orthopedics Today has selected the six most important stories of the year to keep your practice up-to-date regarding platelet-rich plasma (PRP).

A study designed to characterize the secretome of human mesenchymal stem cells in ischemic, hypoxic or normoxic conditions showed the cells release mediators based on nutrient availability, regardless of the oxygen level.